Castle Biosciences Inc Capital Reinvestment Ratio
Castle Biosciences Inc capital reinvestment ratio. Castle Biosciences Inc (CSTL) has a Capital Reinvestment Ratio of 0.57x as of June 2026, meaning it reinvests 1% of its operating cash flow ($15.20 Million) in capital expenditures ($8.65 Million). See Castle Biosciences Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Castle Biosciences Inc (2019–2025)
Capital reinvestment ratio of Castle Biosciences Inc from 2019 to 2025. This chart tracks Castle Biosciences Inc's Capital Reinvestment Ratio across 4 annual periods. See Castle Biosciences Inc (CSTL) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Castle Biosciences Inc Capital Reinvestment Ratio by Year (2019–2025)
Castle Biosciences Inc capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see CSTL operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | $64.35 Million | $36.02 Million | ▲ +28.2% |
| 2024 | 0.44x | $64.87 Million | $28.33 Million | ▼ -9.3% |
| 2020 | 0.48x | $9.87 Million | $4.75 Million | ▲ +260.6% |
| 2019 | 0.13x | $7.01 Million | $937.00K | — |